The full-scale war took away this opportunity from Ukrainians, as enrollment in all active clinical trials was halted, and Ukraine unfortunately does not appear as a potential participant in new research.
According to NCCN and ESMO standards, clinical trials are a recommended method for treating malignant tumors. Often, it is the only chance for patients to live longer and better.
This was detailed in an interview with the specialized publication Scrip by Ivan Vyshnivetsky, the President of the Ukrainian Association of Clinical Trials, and Veronika Patsko, an oncologist at the National Cancer Institute.
Read the article using the provided link.